1. Introduction
The modern terminology of inflammation has been derived from the Latin word
2. Pattern recognition receptors (PRRs) in inflammation and inflammatory diseases
The receptors expressed by these immune cells called
3. Immunometabolism in inflammation and inflammatory diseases
Like, other non-immune cells, immune cells also have their energy demand that plays a crucial role in the maintenance of immune homeostasis and the mounting of the immune response to protect against invading foreign agents, including the pathogen and allergen. The metabolic changes occurring in immune cells from their normal/control stage (absence of inflammogen, pathogen, PAMPs, MAMPs, or DAMPs) to their activation or activated stage is called immunometabolic reprogramming [28]. Hence, the metabolic pathways governing or regulating the energy demand of immune cells to maintain immune homeostasis is called
4. Epigenetics in inflammation and inflammatory diseases
5. Extracellular vesicles in inflammation and inflammatory diseases
6. MicroRNAs (miRNA) in inflammation and inflammatory diseases
7. Conclusion
The story of inflammation had started from the Ancient Indian peninsula through the Ayurvedic medicine that further developed into its four peculiar signs (
References
- 1.
Kumar V. Inflammation research sails through the sea of immunology to reach immunometabolism. International Immunopharmacology. 2019; 73 :128-145 - 2.
Ballakur V. Inflammation in ayurveda and modern medicine. International Ayurvedic Medical Journal. 2013; 1 (4):1-7 - 3.
Rao KVS. Immunology in India: An emerging story. Nature Immunology. 2008; 9 :1319 - 4.
Rocha e Silva, M. A brief survey of the history of inflammation. 1978. Agents and Actions. 1994; 43 :86-90 - 5.
Ley K. History of Inflammation Research. In: Ley K, editor. Physiology of Inflammation. New York, New York, NY: Springer; 2001. pp. 1-10 - 6.
Scott A, Khan KM, Cook JL, Duronio V. What is "inflammation"? Are we ready to move beyond Celsus? British Journal of Sports Medicine. 2004; 38 :248-249 - 7.
Fullerton JN, Gilroy DW. Resolution of inflammation: a new therapeutic frontier. Nature Reviews Drug Discovery. 2016; 15 :551 - 8.
Shalapour S, Karin M. Immunity, inflammation, and cancer: an eternal fight between good and evil. The Journal of Clinical Investigation. 2015; 125 :3347-3355 - 9.
Chen Z, Bozec A, Ramming A, Schett G. Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis. Nature Reviews Rheumatology. 2019; 15 :9-17 - 10.
Shen HH, Yang YX, Meng X, Luo XY, Li XM, Shuai ZW, et al. NLRP3: A promising therapeutic target for autoimmune diseases. Autoimmunity Reviews. 2018; 17 :694-702 - 11.
Kumar V, Ahmad A. Role of MAIT cells in the immunopathogenesis of inflammatory diseases: New players in old game. International Reviews of Immunology. 2017:1-21 - 12.
Kumar V. Innate lymphoid cells: new paradigm in immunology of inflammation. Immunology Letters. 2014; 157 :23-37 - 13.
Kumar V, Sharma A. Neutrophils: Cinderella of innate immune system. International Immunopharmacology. 2010; 10 :1325-1334 - 14.
Kumar V, Sharma A. Mast cells: emerging sentinel innate immune cells with diverse role in immunity. Molecular Immunology. 2010; 48 :14-25 - 15.
Weiss E, Kretschmer D. Formyl-peptide receptors in infection, inflammation, and cancer. Trends in Immunology. 2018; 39 :815-829 - 16.
Kawai T, Akira S. The roles of TLRs, RLRs and NLRs in pathogen recognitionInt Immunol. 21:313. International Immunology. 2009; 21 :317-337 - 17.
Kanneganti T-D, Lamkanfi M, Núñez G. Intracellular NOD-like receptors in host defense and disease. Immunity. 2007; 27 :549-559 - 18.
Kumar V. Inflammasomes: Pandora's box for sepsis. Journal of Inflammation Research. 2018; 11 :477-502 - 19.
Guo H, Callaway JB, Ting JPY. Inflammasomes: mechanism of action, role in disease, and therapeutics. Nature Medicine. 2015; 21 :677-687 - 20.
Hanamsagar R, Hanke ML, Kielian T. Toll-like receptor (TLR) and inflammasome actions in the central nervous system. Trends in Immunology. 2012; 33 :333-342 - 21.
Kumar V. The complement system, toll-like receptors and inflammasomes in host defense: Three musketeers’ one target. International Reviews of Immunology. 2019; 38 :131-156 - 22.
Kumar V. A STING to inflammation and autoimmunity. Journal of Leukocyte Biology. 2019; 106 :171-185 - 23.
Decout A, Katz JD, Venkatraman S, Ablasser A. The cGAS–STING pathway as a therapeutic target in inflammatory diseases. Nature Reviews Immunology. 2021; 21 :548-569 - 24.
Kumar V. The Trinity of cGAS, TLR9, and ALRs Guardians of the Cellular Galaxy Against Host-Derived Self-DNA. Frontiers in Immunology. 2020; 11 :624597 - 25.
Kumar V. Toll-like receptors in immunity and inflammatory diseases: Past, present, and future. International Immunopharmacology. 2018; 59 :391-412 - 26.
Kumar V. Toll-like receptors in the pathogenesis of neuroinflammation. Journal of Neuroimmunology. 2019; 332 :16-30 - 27.
Kumar V. Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets. International Immunopharmacology. 2020; 89 :107087 - 28.
O'Neill LAJ, Kishton RJ, Rathmell J. A guide to immunometabolism for immunologists. Nature Reviews Immunology. 2016; 16 :553-565 - 29.
Voss K, Hong HS, Bader JE, Sugiura A, Lyssiotis CA, Rathmell JC. A guide to interrogating immunometabolism. Nature Reviews Immunology. 2021; 21 :637-652 - 30.
Kumar V. T cells and their immunometabolism: A novel way to understanding sepsis immunopathogenesis and future therapeutics. European Journal of Cell Biology. 2018; 97 :379-392 - 31.
Kumar V. Targeting macrophage immunometabolism: Dawn in the darkness of sepsis. International Immunopharmacology. 2018; 58 :173-185 - 32.
Kumar V. How could we forget immunometabolism in SARS-CoV2 infection or COVID-19? International Reviews of Immunology. 2021; 40 :72-107 - 33.
Kumar V. Immunometabolism: Another Road to Sepsis and Its Therapeutic Targeting. Inflammation. 2019; 42 :765-788 - 34.
Kumar V. Dendritic cells in sepsis: Potential immunoregulatory cells with therapeutic potential. Molecular Immunology. 2018; 101 :615-626 - 35.
Kumar V. Natural killer cells in sepsis: Underprivileged innate immune cells. European Journal of Cell Biology. 2019; 98 :81-93 - 36.
Shanmugam MK, Sethi G. Role of epigenetics in inflammation-associated diseases. Sub-Cellular Biochemistry. 2013; 61 :627-657 - 37.
Adcock IM, Tsaprouni L, Bhavsar P, Ito K. Epigenetic regulation of airway inflammation. Current Opinion in Immunology. 2007; 19 :694-700 - 38.
Schmidt AD, de Guzman Strong C. Current understanding of epigenetics in atopic dermatitis. Experimental Dermatology. 2021; 30 :1150-1155 - 39.
Nielsen HM, Tost J. Epigenetic changes in inflammatory and autoimmune diseases. Sub-Cellular Biochemistry. 2013; 61 :455-478 - 40.
Stylianou E. Epigenetics of chronic inflammatory diseases. Journal of Inflammation Research. 2018; 12 :1-14 - 41.
Surace AEA, Hedrich CM. The Role of Epigenetics in Autoimmune/Inflammatory Disease. Frontiers in Immunology. 2019; 10 :1-16 - 42.
Karin M, Shalapour S. Regulation of antitumor immunity by inflammation-induced epigenetic alterations. Cellular & Molecular Immunology. 2021:1-8 - 43.
Guzik TJ, Cosentino F. Epigenetics and Immunometabolism in Diabetes and Aging. Antioxidants & Redox Signaling. 2018; 29 :257-274 - 44.
Raghuraman S, Donkin I, Versteyhe S, Barrès R, Simar D. The emerging role of epigenetics in inflammation and immunometabolism. Trends in Endocrinology and Metabolism. 2016; 27 :782-795 - 45.
Verberk SGS, de Goede KE, Van den Bossche J. Metabolic–epigenetic crosstalk in macrophage activation: an updated view. Epigenomics. 2019; 11 :719-721 - 46.
Dunn J, Rao S. Epigenetics and immunotherapy: The current state of play. Molecular Immunology. 2017; 87 :227-239 - 47.
Kumar V, Kiran S, Kumar S, Singh UP. Extracellular vesicles in obesity and its associated inflammation. International Reviews of Immunology. 2021:1-15 - 48.
Claßen L, Tykocinski LO, Wiedmann F, Birr C, Schiller P, Tucher C, et al. Extracellular vesicles mediate intercellular communication: Transfer of functionally active microRNAs by microvesicles into phagocytes. European Journal of Immunology. 2017; 47 :1535-1549 - 49.
Andres J, Smith LC, Murray A, Jin Y, Businaro R, Laskin JD, et al. Role of extracellular vesicles in cell-cell communication and inflammation following exposure to pulmonary toxicants. Cytokine & Growth Factor Reviews. 2020; 51 :12-18 - 50.
de Candia P, De Rosa V, Gigantino V, Botti G, Ceriello A, Matarese G. Immunometabolism of human autoimmune diseases: from metabolites to extracellular vesicles. FEBS Letters. 2017; 591 :3119-3134 - 51.
Zhou Z, Tao Y, Zhao H, Wang Q . Adipose extracellular vesicles: Messengers from and to macrophages in regulating immunometabolic homeostasis or disorders. Frontiers in Immunology. 2021; 12 :666344-666344 - 52.
Buzas EI, György B, Nagy G, Falus A, Gay S. Emerging role of extracellular vesicles in inflammatory diseases. Nature Reviews Rheumatology. 2014; 10 :356-364 - 53.
Li Y, Tan J, Miao Y, Zhang Q . MicroRNA in extracellular vesicles regulates inflammation through macrophages under hypoxia. Cell Death Discovery. 2021; 7 :285 - 54.
Burgelman M, Vandendriessche C, Vandenbroucke RE. Extracellular vesicles: A double-edged sword in sepsis. Pharmaceuticals (Basel). 2021; 14 (8):1-40 - 55.
Kronstadt SM, Pottash AE, Levy D, Wang S, Chao W, Jay SM. Therapeutic potential of extracellular vesicles for sepsis treatment. Advanced Therapeutics (Weinh). 2021; 4 (7):1-29 - 56.
Xia X, Yuan P, Liu Y, Wang Y, Cao W, Zheng JC. Emerging roles of extracellular vesicles in COVID-19, a double-edged sword? Immunology. 2021; 163 :416-430 - 57.
Sonkoly E, Pivarcsi A. microRNAs in inflammation. International Reviews of Immunology. 2009; 28 :535-561 - 58.
Sonkoly E, Ståhle M, Pivarcsi A. MicroRNAs and immunity: Novel players in the regulation of normal immune function and inflammation. Seminars in Cancer Biology. 2008; 18 :131-140 - 59.
Tahamtan A, Teymoori-Rad M, Nakstad B, Salimi V. Anti-inflammatory microRNAs and their potential for inflammatory diseases treatment. Frontiers in Immunology. 2018; 9 :1-4 - 60.
Mehta A, Baltimore D. MicroRNAs as regulatory elements in immune system logic. Nature Reviews Immunology. 2016; 16 :279-294 - 61.
Zhou X, Li X, Wu M. miRNAs reshape immunity and inflammatory responses in bacterial infection. Signal Transduction and Targeted Therapy. 2018; 3 :14 - 62.
Yao Q , Song Z, Wang B, Zhang JA. Emerging roles of microRNAs in the metabolic control of immune cells. Cancer Letters. 2018; 433 :10-17 - 63.
Nelson MC, O'Connell RM. MicroRNAs: At the Interface of Metabolic Pathways and Inflammatory Responses by Macrophages. Frontiers in Immunology. 2020; 11 :1797 - 64.
Wang W, Yang N, Yang YH, Wen R, Liu CF, Zhang TN. Non-coding RNAs: Master regulators of inflammasomes in inflammatory diseases. Journal of Inflammation Research. 2021; 14 :5023-5050 - 65.
Rose SA, Wroblewska A, Dhainaut M, Yoshida H, Shaffer JM, Bektesevic A, et al. A microRNA expression and regulatory element activity atlas of the mouse immune system. Nature Immunology. 2021; 22 :914-927